Interestingly, while the number of T cells remained unchanged in the tumor and lymph organs, those found in the tumor and TDLN following NTP treatment expressed more activation (ICOS+/PD1+, IFN‐γ) and less exhaustion (Tim3+/PD1+) markers. The gene discussed is ICOS; the disease is neoplasm.